Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.64
+0.26 (3.60%)
At close: Oct 28, 2026, 4:00 PM EDT
7.60
-0.03 (-0.43%)
After-hours: Oct 28, 2026, 4:46 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $504.3 million as of October 28, 2026. It is the 14,658th most valuable company in the world and the 2,762nd biggest in the United States. Its market cap has increased by 7.99% in one year.
Market Cap
504.30M
Enterprise Value
623.93M
1-Year Change
7.99%
Global Rank
Country Rank
#2,762 United States
Category
ChartMarket Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $504.30M, an increase of 85.88%. That is a compound annual growth rate of 7.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 504.30M | 16.98% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 748.78M |
| Evotec SE | 588.33M |
| Ironwood Pharmaceuticals | 579.99M |
| Aquestive Therapeutics | 510.83M |
| Kamada | 450.43M |
| Alpha Teknova | 438.71M |
| Tilray Brands | 406.26M |
| Emergent BioSolutions | 341.99M |